Century Therapeutics, Inc. (NASDAQ:IPSC) Receives $10.00 Consensus PT from Brokerages
Shares of Century Therapeutics, Inc. (NASDAQ:IPSC – Get Free Report) have been assigned an average recommendation of “Buy” from the five analysts that are currently covering the company, Marketbeat Ratings reports. Five research analysts have rated the stock with a buy recommendation. The average 12 month price target among analysts that have covered the stock […]
Shares of Century Therapeutics, Inc. (NASDAQ:IPSC – Get Free Report) have been assigned an average recommendation of “Buy” from the five analysts that are currently covering the company, Marketbeat Ratings reports. Five research analysts have rated the stock with a buy recommendation. The average 12 month price target among analysts that have covered the stock […]
